PEP-Hans Brazil: Acceptability of Leprosy Chemoprophylaxis in an Endemic Area

The PEP-Hans Brazil Project dataset contains qualitative interview data on the acceptability of single-dose rifampicin chemoprophylaxis (PEP) for leprosy. It includes responses from 80 individuals, comprising 54 contacts, 11 index cases, and 15 health professionals, collected in Alta Floresta, Mato Grosso State, Brazil, in July 2016. The data was analyzed using QRS NVivo software version 10 by author Denise da Costa Boamorte Cortela.

Use Cases

• Analyzing factors influencing medication acceptance based on themes like fear, trust, and protection mentioned in the description.
• Modeling relationships between participant understanding and care by the health team as described in the study.
• Studying expectations towards health interventions based on concepts like wellbeing, disease prevention, and public expenditure reduction.
• Investigating the role of prior information in strengthening trust in health professionals and medication acceptance.

Strengths

• Includes data from 80 participants across three distinct stakeholder groups: contacts, index cases, and health professionals.
• Provides a high acceptance rate detail: 94% of contacts (51 out of 54) took the chemoprophylaxis.
• Identifies three specific qualitative categories for analysis: understanding, acceptance, and expectation towards the intervention.

Limitations

• Row count for the underlying qualitative data is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect geographic and temporal bias inherent to a single study location and time point.

Provenance

Source

Denise da Costa Boamorte Cortela

Collection Method

Semi-structured interviews conducted according to the LPEP program (2016) protocol, with qualitative content analysis performed.

Time Range

July 2016

Geography

Alta Floresta, Mato Grosso State, Brazil